First U.S. Citizen Receives New Ketamine Treatment for Alcohol Use Disorder

The treatment, developed by Awakn Life Science, was administered today in New York City at the Nushama ketamine clinic.

Psilocybin-assisted Therapy is Officially Legal in Oregon

The Oregon Health Authority has released the final version of rules that will apply to all aspects of psilocybin treatment in Oregon, which became legal on January 1.

Verdict in Lawsuit Assigns MAPS 25% Liability and $1M in Damages

A jury in Monterey California has returned a verdict that found MAPS liable in a wrongful death lawsuit. 

MAPS Found Liable in Wrongful Death Lawsuit

After a three-week trial, a jury found MAPS partially responsible for the wrongful death of a woman cared for in the Zendo Project peer support space and liable for damages.

Long-term Ketamine Treatment for Depression May Reduce Risk of Relapse

A first-of-its-kind review suggests that regular treatments are effective at reducing risk of relapse, though researchers say more study is needed.

MAPS Prepares For Trial in Wrongful Death Lawsuit

The MAPS nonprofit faces a jury trial next week to address a lawsuit brought by the family of a woman who died after being at the Zendo care space at a music festival in 2017.

Remembering Ann Shulgin and What She Taught Us About the Shadow 

The legendary pioneer of psychedelic-assisted therapy leaves behind a legacy of wisdom for healers and explorers of the subconscious.

Psychedelic Therapy Training Programs Expand To Meet Demand

As the need for psychedelic therapists expands, more training programs emerge to meet the needs of patients.

Survey Finds Those Who Take Psilocybin Less Likely to Abuse Opioids

Researchers are exploring possible causal links between use of magic mushrooms and opioid dependency.

Researchers May Have Created LSD-Analogs that Treat Depression Without the Trip

If proven safe and effective in humans, such “no-trip psychedelics” could potentially deliver relief from depression and other mental health conditions to millions more people than could traditional psychedelics.